HYPOTHESIS AND THEORY article

Front. Pediatr., 16 February 2022

Sec. Genetics of Common and Rare Diseases

Volume 9 - 2021 | https://doi.org/10.3389/fped.2021.708555

RETRACTED: ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway

Retracted

A retraction of this article was approved in:

  1. Retraction: ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway Author: Frontiers Editorial Office*

    1. Read retraction
Zhen Ding&#x;Zhen Ding1†Fei Yu&#x;Fei Yu1†Yan Sun Yan Sun2*Ning Jiao&#x;Ning Jiao1‡Lina Shi&#x;Lina Shi1‡Jinghong WanJinghong Wan1Qinghua LiuQinghua Liu1
  • 1Department of Pediatrics, Zibo Hospital of Traditional Chinese Medicine, Zibo, China
  • 2Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Ding Z, Yu F, Sun Y, Jiao N, Shi L, Wan J and Liu Q (2022) ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway. Front. Pediatr. 9:708555. doi: 10.3389/fped.2021.708555

Received: 12 May 2021; Accepted: 09 December 2021;
Published: 16 February 2022; Retracted: 16 June 2025.

Edited by:

Stefania Martucciello, University of Salerno, Italy

Reviewed by:

Shaoxi Cai, Southern Medical University, China
Sinem Firtina, University of Istinye, Turkey

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.